Refractory Epilepsy study: DBS Setting Optimization
Official title Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
ClinicalTrials.gov ID: NCT05493722
What this study is testing
- What it's testing
- This study is testing whether a new tool can help doctors find the best settings for your brain stimulator. It aims to make the treatment work better for each person.
- Who it's for
- You may be able to join if you have epilepsy that does not get better with medicine and you already have a brain stimulator.
- What's involved
- You would keep your current brain stimulator. The team would use a new method to check your brain signals and adjust the machine's settings.
- Time commitment
- The source text does not say how long the study lasts or how many visits are needed.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- medically refractory epilepsy
- already have a deep brain stimulator in place
You likely can't join if
- severe dementia at investigator discretion
The study team makes the final eligibility decision.
Where it is enrolling
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Minneapolis, Minnesota, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.